View Financial HealthBBIA 配当と自社株買い配当金 基準チェック /36BBIA配当を支払う会社であり、現在の利回りは1.77%で、収益によって十分にカバーされています。主要情報1.8%配当利回り1.9%バイバック利回り総株主利回り3.7%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向39%最近の配当と自社株買いの更新お知らせ • Dec 12BBIA Co., Ltd. (KOSDAQ:A451250) announces an Equity Buyback for KRW 2,000 million worth of its shares.BBIA Co., Ltd. (KOSDAQ:A451250) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,000 million worth of its shares pursuant to a contract with Shinyoung Securities Co., Ltd. The purpose of the share repurchase is stock price stabilization and to enhance shareholder value. The repurchase program will expire on June 9, 2025. As of December 9, 2024, the company had no shares within scope available for dividend and had 196,540 shares in treasury through other repurchase.すべての更新を表示Recent updatesお知らせ • Feb 24BBIA Co., Ltd., Annual General Meeting, Mar 27, 2026BBIA Co., Ltd., Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 123, central-ro, yeonsu-gu, incheon South KoreaValuation Update With 7 Day Price Move • Nov 26Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩10,440, the stock trades at a trailing P/E ratio of 26.9x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 16% over the past year.分析記事 • Nov 21BBIA's (KOSDAQ:451250) Returns On Capital Not Reflecting Well On The BusinessIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Reported Earnings • Nov 19Third quarter 2025 earnings released: EPS: ₩147 (vs ₩177 in 3Q 2024)Third quarter 2025 results: EPS: ₩147 (down from ₩177 in 3Q 2024). Revenue: ₩18.7b (up 33% from 3Q 2024). Net income: ₩1.44b (down 15% from 3Q 2024). Profit margin: 7.7% (down from 12% in 3Q 2024). The decrease in margin was driven by higher expenses.Valuation Update With 7 Day Price Move • Sep 22Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩11,340, the stock trades at a trailing P/E ratio of 27.4x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 14% over the past year.New Risk • May 23New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 24% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 144% Paying a dividend despite having no free cash flows. High level of non-cash earnings (24% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Profit margins are more than 30% lower than last year (1.6% net profit margin). Market cap is less than US$100m (₩110.5b market cap, or US$80.4m).New Risk • May 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 228% Paying a dividend despite having no free cash flows. Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Profit margins are more than 30% lower than last year (1.1% net profit margin). Market cap is less than US$100m (₩108.2b market cap, or US$77.4m).分析記事 • May 08What You Can Learn From BBIA Co., Ltd.'s (KOSDAQ:451250) P/SBBIA Co., Ltd.'s ( KOSDAQ:451250 ) price-to-sales (or "P/S") ratio of 2.1x may not look like an appealing investment...お知らせ • Feb 27BBIA Co., Ltd., Annual General Meeting, Mar 28, 2025BBIA Co., Ltd., Annual General Meeting, Mar 28, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 123, central-ro, yeonsu-gu, incheon South Koreaお知らせ • Dec 12BBIA Co., Ltd. (KOSDAQ:A451250) announces an Equity Buyback for KRW 2,000 million worth of its shares.BBIA Co., Ltd. (KOSDAQ:A451250) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,000 million worth of its shares pursuant to a contract with Shinyoung Securities Co., Ltd. The purpose of the share repurchase is stock price stabilization and to enhance shareholder value. The repurchase program will expire on June 9, 2025. As of December 9, 2024, the company had no shares within scope available for dividend and had 196,540 shares in treasury through other repurchase.分析記事 • Dec 09BBIA Co., Ltd.'s (KOSDAQ:451250) 25% Cheaper Price Remains In Tune With RevenuesUnfortunately for some shareholders, the BBIA Co., Ltd. ( KOSDAQ:451250 ) share price has dived 25% in the last thirty...New Risk • Aug 05New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩117.2b (US$85.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (16% average weekly change). Minor Risk Market cap is less than US$100m (₩117.2b market cap, or US$85.9m).決済の安定と成長配当データの取得安定した配当: A451250は配当の支払いを開始したばかりなので、配当金の支払いが安定しているかどうかを判断するのは時期尚早です。増加する配当: A451250は配当の支払いを開始したばかりなので、配当金が増加するかどうかを判断するのは時期尚早です。 配当利回り対市場BBIA 配当利回り対市場A451250 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (A451250)1.8%市場下位25% (KR)0.9%市場トップ25% (KR)3.5%業界平均 (Chemicals)1.1%アナリスト予想 (A451250) (最長3年)n/a注目すべき配当: A451250の配当金 ( 1.77% ) はKR市場の配当金支払者の下位 25% ( 0.94% ) よりも高くなっています。高配当: A451250の配当金 ( 1.77% ) はKR市場の配当金支払者の上位 25% ( 3.52% ) と比較すると低いです。株主への利益配当収益カバレッジ: A451250の 配当性向 ( 39% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。株主配当金キャッシュフローカバレッジ: A451250は合理的な 現金配当性向 ( 69.9% ) を備えているため、配当金の支払いはキャッシュフローによって賄われます。高配当企業の発掘7D1Y7D1Y7D1YKR 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/08 16:13終値2026/05/08 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋BBIA Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Dec 12BBIA Co., Ltd. (KOSDAQ:A451250) announces an Equity Buyback for KRW 2,000 million worth of its shares.BBIA Co., Ltd. (KOSDAQ:A451250) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,000 million worth of its shares pursuant to a contract with Shinyoung Securities Co., Ltd. The purpose of the share repurchase is stock price stabilization and to enhance shareholder value. The repurchase program will expire on June 9, 2025. As of December 9, 2024, the company had no shares within scope available for dividend and had 196,540 shares in treasury through other repurchase.
お知らせ • Feb 24BBIA Co., Ltd., Annual General Meeting, Mar 27, 2026BBIA Co., Ltd., Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 123, central-ro, yeonsu-gu, incheon South Korea
Valuation Update With 7 Day Price Move • Nov 26Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩10,440, the stock trades at a trailing P/E ratio of 26.9x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 16% over the past year.
分析記事 • Nov 21BBIA's (KOSDAQ:451250) Returns On Capital Not Reflecting Well On The BusinessIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Reported Earnings • Nov 19Third quarter 2025 earnings released: EPS: ₩147 (vs ₩177 in 3Q 2024)Third quarter 2025 results: EPS: ₩147 (down from ₩177 in 3Q 2024). Revenue: ₩18.7b (up 33% from 3Q 2024). Net income: ₩1.44b (down 15% from 3Q 2024). Profit margin: 7.7% (down from 12% in 3Q 2024). The decrease in margin was driven by higher expenses.
Valuation Update With 7 Day Price Move • Sep 22Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩11,340, the stock trades at a trailing P/E ratio of 27.4x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 14% over the past year.
New Risk • May 23New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 24% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 144% Paying a dividend despite having no free cash flows. High level of non-cash earnings (24% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Profit margins are more than 30% lower than last year (1.6% net profit margin). Market cap is less than US$100m (₩110.5b market cap, or US$80.4m).
New Risk • May 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 228% Paying a dividend despite having no free cash flows. Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Profit margins are more than 30% lower than last year (1.1% net profit margin). Market cap is less than US$100m (₩108.2b market cap, or US$77.4m).
分析記事 • May 08What You Can Learn From BBIA Co., Ltd.'s (KOSDAQ:451250) P/SBBIA Co., Ltd.'s ( KOSDAQ:451250 ) price-to-sales (or "P/S") ratio of 2.1x may not look like an appealing investment...
お知らせ • Feb 27BBIA Co., Ltd., Annual General Meeting, Mar 28, 2025BBIA Co., Ltd., Annual General Meeting, Mar 28, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 123, central-ro, yeonsu-gu, incheon South Korea
お知らせ • Dec 12BBIA Co., Ltd. (KOSDAQ:A451250) announces an Equity Buyback for KRW 2,000 million worth of its shares.BBIA Co., Ltd. (KOSDAQ:A451250) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,000 million worth of its shares pursuant to a contract with Shinyoung Securities Co., Ltd. The purpose of the share repurchase is stock price stabilization and to enhance shareholder value. The repurchase program will expire on June 9, 2025. As of December 9, 2024, the company had no shares within scope available for dividend and had 196,540 shares in treasury through other repurchase.
分析記事 • Dec 09BBIA Co., Ltd.'s (KOSDAQ:451250) 25% Cheaper Price Remains In Tune With RevenuesUnfortunately for some shareholders, the BBIA Co., Ltd. ( KOSDAQ:451250 ) share price has dived 25% in the last thirty...
New Risk • Aug 05New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩117.2b (US$85.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (16% average weekly change). Minor Risk Market cap is less than US$100m (₩117.2b market cap, or US$85.9m).